JZAD-IV-22

N/A

Report date: 2022/10/11 16:13:00
NME

Base Information

Drug NameJZAD-IV-22
Drug Alias NameJZAD-IV-22
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine reuptake inhibitorsNorepinephrine reuptake inhibitorsSerotonin reuptake inhibitors
TargetsDopamine transporterNorepinephrine transporterSerotonin transporter
Therapy Area/IndicationsDepression
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPsychogenics
China Registration ClassN/A

Develop Information

Active CompaniesPsychogenics
Inactive CompaniesN/A
Active IndicationsDepression
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A